Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 137 EP applications Christopher Marcus Denison has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12707217

ALKALINE MICROBIAL ENHANCED OIL RECOVERY

IPC classification:
C12N 9/00, C12N 1/26, C09K 8/582
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12749214

MYCOVIRUS, PHYTOPATHOGENIC FUNGUS, PLANT DISEASE CONTROLLING AGENT, METHOD FOR CONTROLLING PLANT DISEASE, AND METHOD FOR ATTENUATING PHYTOPATHOGENIC FUNGUS

IPC classification:
A01P 3/00, A01N 63/00, C12N 7/00, C12N 1/14
Applicant:
Tokyo University of Agriculture and Technology
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13182512

Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin

IPC classification:
A61K 31/66, A61P 35/00, A61K 33/24, A61K 31/282
Applicant:
Ohio University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12768019

PHARMACEUTICAL PREPARATION

IPC classification:
A61K 47/36, A61K 47/34, A61K 45/00, A61K 31/5575, A61K 9/70, A61P 27/06, A61P 27/02
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12710414

BISPECIFIC THREE-CHAIN ANTIBODY-LIKE MOLECULES

IPC classification:
C07K 16/46, C07K 16/00
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12820596

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PROPHYLAXIS OF CANCER

IPC classification:
A61K 39/395, C12P 21/08, C12N 15/09, C07K 16/30, A61P 35/00
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12820225

CANCER TREATMENT AND/OR PREVENTION DRUG COMPOSITION

IPC classification:
A61K 47/48, A61K 39/395, C12P 21/08, C12N 15/09, C07K 16/30, A61P 35/00
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12819473

METHOD FOR DETECTING PANCREATIC CANCER

IPC classification:
G01N 33/574, G01N 33/53, C12Q 1/68, C12P 21/08, C12N 15/02, C07K 16/18, C07K 14/47
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12820775

CANCER TREATMENT AND/OR PREVENTION DRUG COMPOSITION

IPC classification:
A61K 45/00, A61K 39/395, C12N 15/09, C07K 16/30, A61P 35/02, A61P 35/00, A61P 25/00, A61P 17/00, A61P 15/00, A61P 13/12, A61P 13/10, A61P 13/08, A61P 11/00, A61P 1/18, A61P 1/04
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12819759

DRUG COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION

IPC classification:
A61K 48/00, A61K 39/395, C12N 15/09, C07K 16/30, A61P 35/02, A61P 35/00
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The patent has been granted
EP12820091

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PROPHYLAXIS OF CANCER

IPC classification:
A61K 39/395, C12P 21/08, C12N 15/09, C07K 16/30, A61P 35/02, A61P 35/00
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12824560

METHOD FOR PREPARING NUCLEIC ACID APTAMER

IPC classification:
A61K 31/713, A61K 31/711, A61K 31/7088, G01N 33/543, G01N 33/53, C12N 15/115, C12N 15/09, A61P 43/00
Applicant:
Kabushiki Kaisha Riken
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12823302

SOLID-PHASE CARRIER FOR AMINATED OLIGONUCLEOTIDE

IPC classification:
C12Q 1/68, C12N 15/09, C07H 21/04
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12829695

METHOD FOR PRODUCING POLYHYDROXYALKANOATE HAVING LONG MAIN CHAIN STRUCTURE

IPC classification:
C12P 7/62, C12N 15/09
Applicant:
Kabushiki Kaisha Riken
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12836741

MOLECULAR TEMPLATE AND METHOD FOR PRODUCING SAME

IPC classification:
G01N 33/543, G01N 33/53, G01N 21/27
Applicant:
Hitachi Ltd
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12842392

ACTIVATION OF FUNCTIONAL NUCLEIC ACID BY SPECIFIC MODIFICATION

IPC classification:
A61K 48/00, C12N 15/115, C12N 15/113, C12N 15/09
Applicant:
Kabushiki Kaisha Riken
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11802221

PHOSPHAPLATINS HAVING ANTI-ANGIOGENIC, ANTI-METASTATIC, AND PRO-APOPTOTIC PROPERTIES AND USES THEREOF

IPC classification:
A61P 35/04, A61P 35/00, A61K 33/24, A61K 31/282
Applicant:
Ohio University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12845463

METHOD FOR DETECTING CHRONIC SINUSITIS

IPC classification:
G01N 33/53, C12N 15/09, C07K 14/47
Applicant:
Saga University
Applicant:
Yamagata University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12846621

DOUBLE-STRANDED NUCLEIC ACID MOLECULE FOR GENE EXPRESSION CONTROL

IPC classification:
A61K 48/00, A61K 31/7105, C12N 15/113
Applicant:
Osaka City University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12840420

CHIMERIC NON-HUMAN ANIMAL CARRYING HUMAN HEPATOCYTE

IPC classification:
A01K 67/027, G01N 33/50, G01N 33/15
Applicant:
Tottori University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12848980

DEVICE FOR MANUFACTURING SUPPORTING BODY FOR CELL STRUCTURE MANUFACTURE

IPC classification:
C12N 11/00, C12N 5/071, C12M 3/00
Applicant:
Cyfuse Biomedical K. K.
Applicant:
Saga University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12850603

NUCLEIC ACID MOLECULE FOR INHIBITING ACTIVITY OF RNAI MOLECULE

IPC classification:
A61K 31/713, A61K 31/7105, C12N 15/113, A61P 35/00
Applicant:
Osaka City University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12850348

NUCLEIC ACID FRAGMENT BINDING TO TARGET PROTEIN

IPC classification:
A61K 48/00, A61K 31/7115, G01N 33/53, G01N 33/50, G01N 33/15, C40B 40/06, C12Q 1/68, C12N 15/115, C12N 9/00, C07H 21/04, C07H 21/02, A61P 43/00, A61P 9/00
Applicant:
Kabushiki Kaisha Riken
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13177665

Neutralizing molecules to viral antigens

IPC classification:
A61K 39/145, C07K 16/10
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14163686

IL-17 A/F heterologous polypeptides and therapeutics uses thereof

IPC classification:
A61K 39/395, A61K 38/20, G01N 33/53, C12N 15/24, C07K 16/24, C07K 14/54
Applicant:
Genentech, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11863866

COMPOSITION CONTAINING SCIRPUSIN B, AND PROCESS FOR PRODUCING COMPOSITION CONTAINING SCIRPUSIN B

IPC classification:
A61K 8/97, A61K 8/49, A23L 1/30, C07D 307/80, A61Q 19/00
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12760444

COMPOSITION FOR TREATMENT AND DIAGNOSIS OF PANCREATIC CANCER

IPC classification:
A61K 47/48, A61K 39/395, A61K 39/00, A61K 38/16, G01N 33/577, G01N 33/574, G01N 33/543, C12Q 1/02, C12N 15/09, C07K 16/46, C07K 16/30, C07K 16/28, C07K 14/705, A61P 35/04, A61P 35/00, A61P 1/18
Applicant:
Kagoshima University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12790050

LIPOSOME CONTAINING shRNA MOLECULE FOR THYMIDYLATE SYNTHASE, AND USE FOR SAME

IPC classification:
A61K 48/00, A61K 47/28, A61K 47/24, A61K 47/18, A61K 45/00, A61K 31/713, A61K 31/513, A61K 9/127, C12N 15/113, A61P 35/00
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The patent has been granted
EP12862878

MONOCLONAL ANTIBODY FOR DETECTING EXOSOMES

IPC classification:
G01N 33/577, G01N 33/574, G01N 33/543, C12P 21/08, C12N 15/09, C07K 16/18
Applicant:
Shionogi & Co. Limited (Shionogi Seiyaku Kabushiki-gaisha)
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12762975

CELL-ADHESIVE PHOTOCONTROLLABLE BASE MATERIAL

IPC classification:
C12N 5/071, C12M 1/26, C12M 1/14, C12M 1/12, C12M 1/00
Applicant:
Hitachi High-Technologies Corporation
Applicant:
University of Tokyo
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11817443

INFLUENZA VIRUS NEUTRALIZING AGENTS THAT MIMIC THE BINDING SITE OF AN INFLUENZA NEUTRALIZING ANTIBODY

IPC classification:
A61K 39/395, C12N 7/00
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13743114

ANTI-sAPPss ANTIBODY

IPC classification:
G01N 33/53, G01N 33/50, G01N 33/15, C12P 21/08, C12N 15/09, C07K 16/18
Applicant:
Shionogi & Co. Limited (Shionogi Seiyaku Kabushiki-gaisha)
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12741664

TRANSPLANT GUIDING PART AND TRANSPLANT TOOL

IPC classification:
A61L 27/56, A61F 2/00, A61B 17/00, A61L 31/00, A61F 2/02
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13751278

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER

IPC classification:
A61K 39/395, C12P 21/08, C12N 15/09, C07K 16/30, A61P 35/00
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13752353

MEDICINAL COMPOSITION FOR TREATING AND/OR PREVENTING CANCER

IPC classification:
A61K 39/395, C12P 21/08, C12N 15/09, C07K 16/30, A61P 35/00
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The patent has been granted
EP13751159

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER

IPC classification:
A61K 39/395, C12P 21/08, C12N 15/09, C07K 16/30, A61P 35/00
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14153299

Cancer detection method

IPC classification:
G01N 33/574, G01N 33/53, C12Q 1/68, C12N 15/09
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13752554

TLR4 AGENT, TISSUE HOMEOSTASIS AGENT, HEPATOCYTE GROWTH FACTOR INDUCER, TISSUE REPAIRING AGENT, AND SIRTUIN INDUCER HAVING HYALURONIC ACID FRAGMENTS AS ACTIVE INGREDIENTS THEREOF

IPC classification:
A61K 31/728, A61K 31/702, A61K 31/7016, A61K 8/73, A61K 8/60, A23L 1/30, A61P 35/00, A61P 29/00, A61P 25/28, A61P 25/00, A61P 21/00, A61P 19/02, A61P 17/16, A61P 13/12, A61P 11/00, A61P 9/12, A61P 9/10, A61P 3/10, A61P 3/06, A61P 3/04
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13751164

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER

IPC classification:
A61K 39/395, C12P 21/08, C12N 15/09, C07K 16/30, A61P 35/00
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13760866

METHOD FOR PRODUCING CARDIAC AND VASCULAR CELL MIXTURE FROM ARTIFICIAL PLURIPOTENT STEM CELLS

IPC classification:
A61L 27/00, A61K 35/12, C12N 5/071, A61P 9/00
Applicant:
iHeart Japan Corporation
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13767612

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF LIVER CANCER

IPC classification:
A61K 39/395, C12N 15/09, C07K 16/46, C07K 16/18, A61P 35/00
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The patent has been granted
EP13769665

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF GALL BLADDER CANCER

IPC classification:
A61K 39/395, C12N 15/09, C07K 16/46, C07K 16/18, A61P 35/00
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The patent has been granted
EP14185710

Immunity-inducing agent

IPC classification:
A61K 38/00, C12N 15/12, C07K 14/47, A61P 37/04, A61P 35/00
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13189711

Use of anti-vegf antibody in combination with chemotherapy for treating breast cancer

IPC classification:
A61K 45/06, A61K 39/395, A61K 31/704, A61K 31/675, A61K 31/513, A61K 31/337, A61P 35/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12819899

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF PANCREATIC CANCER

IPC classification:
A61K 45/00, A61K 39/395, C07K 16/28, C07K 14/47, A61P 43/00, A61P 35/00, A61P 1/18
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13782578

THERAPEUTIC AGENT FOR INJURY IN EPITHELIUM AND ENDOTHELIUM

IPC classification:
A61K 38/00, C07K 14/745, A61P 43/00, A61P 31/04, A61P 11/06, A61P 9/14, A61P 9/10, A61P 7/10, A61P 7/02
Applicant:
Nihon University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14191456

Anti-VEGF antibodies

IPC classification:
A61K 39/395, C12N 15/13, C07K 16/32, C07K 16/22, C07K 16/00, A61P 35/00
Applicant:
Genentech, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14814684

SLIDING SEISMIC ISOLATION DEVICE

IPC classification:
F16F 15/02, E04H 9/02
Applicant:
Nippon Steel & Sumikin Engineering Co., Ltd.
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13806792

IgE PEPTIDE VACCINE

IPC classification:
A61K 39/00, C07K 16/00, C07K 14/47, C07K 7/08, A61P 37/08, A61P 37/04, A61P 37/02, A61P 27/02, A61P 17/04, A61P 17/00, A61P 11/06, A61P 11/02
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13816104

ANTITUMOR AGENT, MARKER FOR TUMOR DETECTION, AND ORAL VACCINE AGENT

IPC classification:
A61K 48/00, A61K 39/02, A61K 35/74, C12Q 1/04, C12N 15/09, C12N 1/21, C07K 19/00, C07K 16/00, A61P 35/00
Applicant:
Teikyo Heisei University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13820574

METHOD FOR DETECTING CANCER

IPC classification:
G01N 33/577, G01N 33/574, G01N 33/53, G01N 33/48, C12P 21/08, C12N 15/02, C07K 16/18
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13820185

METHOD FOR DETECTING CANCER

IPC classification:
G01N 33/577, G01N 33/574, G01N 33/53, G01N 33/48, C12N 15/09
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13748450

COMBINATION THERAPY FOR THE TREATMENT OF GLIOBLASTOMA

IPC classification:
A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP15155019

Method of detecting ocular diseases and pathologic conditions and treatment of same

IPC classification:
A61K 39/395, G01N 33/53, C12Q 1/68, C07K 16/00
Applicant:
University of Utah Research Foundation
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11847931

METHOD FOR ENRICHMENT AND SEPARATION OF SPINAL FLUID GLYCOPROTEIN, METHOD FOR SEARCHING FOR MARKER FOR CENTRAL NERVOUS SYSTEM DISEASES WHICH UTILIZES THE AFOREMENTIONED METHOD, AND MARKER FOR CENTRAL NERVOUS SYSTEM DISEASES

IPC classification:
G01N 33/68, G01N 33/53, G01N 33/50, C07K 1/22
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP15179184

THIN FILM-LIKE POLYMER STRUCTURE AND METHOD FOR PREPARING THE SAME

IPC classification:
C12N 5/00, B32B 38/10, B32B 37/02, A61K 9/70, A61K 9/00, C08J 7/12, C08J 5/18, B82B 3/00, B82B 1/00, B32B 9/00
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The patent has been granted
EP14757511

CHIMERIC SINGLE-STRANDED ANTISENSE POLYNUCLEOTIDES AND DOUBLE-STRANDED ANTISENSE AGENT

IPC classification:
A61P 43/00, A61K 48/00, A61K 31/7088, C12N 15/09
Applicant:
Tokyo Medical and Dental University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13878105

CARDIAC OR VASCULAR TISSUE SPHEROID

IPC classification:
C12N 5/077, C12N 5/071, A61L 27/00
Applicant:
Saga University
Applicant:
Cyfuse Biomedical K. K.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14769566

ANTI-DOG IGE MONOCLONAL ANTIBODY, AND LIGHT-CHAIN VARIABLE REGION AND HEAVY-CHAIN VARIABLE REGION OF ANTI-DOG IGE MONOCLONAL ANTIBODY

IPC classification:
G01N 33/53, C12P 21/08, C12N 15/09, C12N 5/10, C12N 1/21, C12N 1/19, C12N 1/15, C07K 16/42
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14782540

METHOD FOR DETECTING COLON CANCER

IPC classification:
C12P 21/08, C07K 16/28, G01N 33/53, G01N 33/574
Applicant:
Shionogi & Co. Limited (Shionogi Seiyaku Kabushiki-gaisha)
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13883388

LOCALLY ADMINISTERED LIPOSOME AND APPLICATION THEREFOR

IPC classification:
C12N 15/113, C12N 15/09, A61P 43/00, A61P 35/00, A61K 48/00, A61K 47/48, A61K 47/24, A61K 47/18, A61K 45/00, A61K 31/713, A61K 31/7088, A61K 31/519, A61K 9/127
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14804901

DOUBLE-STRANDED AGENTS FOR DELIVERING THERAPEUTIC OLIGONUCLEOTIDES

IPC classification:
C12N 15/09
Applicant:
Tokyo Medical and Dental University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14814254

DOUBLE-STRANDED ANTISENSE NUCLEIC ACID WITH EXON-SKIPPING EFFECT

IPC classification:
A61P 21/00, A61K 31/713
Applicant:
Osaka University
Applicant:
Tokyo Medical and Dental University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13170810

Isolated renal cells and uses thereof

IPC classification:
A61K 35/12, C12N 5/071
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The patent has been granted
EP14834828

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER

IPC classification:
C12P 21/08, C12N 15/09, C07K 16/46, A61P 35/02, A61P 35/00, A61K 45/00, A61K 39/395, C07K 16/18
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14837292

POLYMER NANOPARTICLE COMPOSITE AND COMPOSITION FOR MRI IMAGING INCLUDING SAME

IPC classification:
A61K 49/00
Applicant:
University of Tokyo
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13888417

NATURAL BINDING AUXILIARY MATERIAL, DERIVED FROM LIPOPHILIC PITH FIBERS (GROUND INNER STEM FIBERS) SEPARATED FROM SUNFLOWER STEMS, FOR PROCESSED FOODS, AND PROCESSED FOOD CONTAINING SAME

IPC classification:
A23G 1/32, A21D 2/36, A23G 3/48, A23G 1/48, A23G 1/12, A21D 13/08, A23L 13/60, A23L 13/50, A23L 7/109, A23G 1/30, A23G 1/00, A23L 29/00
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14839506

METHOD FOR PRODUCING POROUS CELLULOSE PARTICLES, AND POROUS CELLULOSE PARTICLES

IPC classification:
G01N 30/88, C08B 3/06, C08J 3/14
Applicant:
JNC Corporation
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14766628

CONSTANT CHAIN MODIFIED BISPECIFIC, PENTA- AND HEXAVALENT IG-M ANTIBODIES

IPC classification:
C07K 16/28, C07K 16/00
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15196523

EGFR MUTATIONS

IPC classification:
C07H 21/04, G01N 33/53, C12Q 1/68
Applicant:
Genentech, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14783694

MICROBIAL ENHANCED OIL RECOVERY METHOD

IPC classification:
C12R 1/01, C12P 1/04, C12P 19/00, C09K 8/582
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14852637

IMMUNOPOTENTIATOR

IPC classification:
A61P 43/00, A61P 37/04, A61K 47/48, A61K 47/34, A61K 39/00, A61K 31/716
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15866532

REINFORCEMENT STRUCTURE FOR EXISTING BUILDINGS

IPC classification:
E04G 23/02
Applicant:
Nippon Steel & Sumikin Engineering Co., Ltd.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15845301

CELL TRAY AND DEVICE, METHOD AND SYSTEM FOR PRODUCING CELL STRUCTURE

IPC classification:
C12N 11/02, C12N 5/07, C12M 1/00
Applicant:
Cyfuse Biomedical K. K.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The patent has been granted
EP16171215

ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF PREVIOUSLY TREATED BREAST CANCER

IPC classification:
A61P 35/00, A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14878071

RECOMBINANT ANAEROBIC GRAM-POSITIVE BACTERIA

IPC classification:
C12P 21/08, C12N 15/09, C07K 16/28, A61P 35/00, A61K 35/74, C12N 1/21
Applicant:
Teikyo Heisei University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16164548

VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS

IPC classification:
A61P 35/00, A61K 39/395, A61K 38/43, A61K 38/19, A61K 38/17
Applicant:
Genentech, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP16167119

ELISA FOR VEGF

IPC classification:
G01N 33/74, C07K 16/22
Applicant:
Genentech, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16181429

METHOD FOR DETECTION OF CANCER

IPC classification:
C12N 15/09, G01N 33/53, C12Q 1/68, G01N 33/574
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16181416

METHOD FOR DETECTION OF CANCER

IPC classification:
C12N 15/09, G01N 33/53, C12Q 1/68, G01N 33/574
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15706611

IGA MULTI-SPECIFIC BINDING MOLECULES

IPC classification:
C07K 16/12, C07K 16/10
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16181433

METHOD FOR DETECTION OF CANCER

IPC classification:
C12N 15/09, G01N 33/53, C12Q 1/68, G01N 33/574
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16169756

IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

IPC classification:
C12Q 1/00, A61K 38/19, C07K 16/24, C12N 15/62, C12Q 1/68, C12N 1/19, C12N 1/21, C12N 5/10, C07K 14/52, C12N 15/19
Applicant:
Genentech, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP15758536

PLANT TRANSFORMATION METHOD

IPC classification:
A01H 5/00, C12N 15/09
Applicant:
Kabushiki Kaisha Riken
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15768501

PROCESS AND DEVICE FOR PRODUCING FUEL HYDROCARBON OIL

IPC classification:
C10L 1/00
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15718304

MODIFIED J-CHAIN

IPC classification:
C07K 16/00
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16173372

HUMAN ANTI-PD-1, PD-L1, AND PD-L2 ANTIBODIES AND USES THEREOF

IPC classification:
A61P 35/00, A61P 31/00, A61K 39/395, C07K 16/28
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
Emory University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP15793392

HEAT STORAGE BODY COMPRISING POROUS BASE MATERIAL IMPREGNATED WITH LATENT HEAT STORAGE MATERIAL, AND METHOD FOR PRODUCING SAME

IPC classification:
F28D 20/02, C09K 5/06
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16196385

MICROBIAL ENHANCED OIL RECOVERY METHODS

IPC classification:
C09K 8/00, E21B 43/16, C12N 9/02, C12N 1/26
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP15800550

PANCREATIC CANCER DETECTION KIT, DEVICE, AND DETECTION METHOD

IPC classification:
G01N 37/00, G01N 33/574, G01N 33/53, C12Q 1/68, C12M 1/34, C12M 1/00, C12N 15/09
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16185311

ANTI-EPHB4 ANTIBODIES AND METHODS USING SAME

IPC classification:
A61P 35/00, A61K 39/395, G01N 33/53, C12N 5/10, C12N 15/63, C12N 15/13, C07K 16/30, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP15806013

COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD

IPC classification:
G01N 33/574, G01N 33/53, C12N 15/113, C12N 15/09, C12M 1/00, C12Q 1/68
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15806052

PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD

IPC classification:
G01N 37/00, G01N 33/574, G01N 33/53, C12Q 1/68, C12M 1/34, C12M 1/00, C12N 15/09
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15806290

DETECTION KIT OR DEVICE AND DETECTION METHOD FOR BILIARY TRACT CANCER

IPC classification:
G01N 37/00, G01N 33/566, G01N 33/53, C12N 15/09, C12Q 1/68
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15809520

STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD

IPC classification:
G01N 37/00, G01N 33/53, C12Q 1/68
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15805922

BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER

IPC classification:
C12N 15/09, C12M 1/00, C12Q 1/68
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15728355

ANTI-PD-L1 ANTIBODIES AND DIAGNOSTIC USES THEREOF

IPC classification:
G01N 33/53, C07K 16/28
Applicant:
Ventana Medical Systems, Inc.
Applicant:
Genentech, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16202867

ANTI-VEGF ANTIBODIES

IPC classification:
C12N 15/13, A61P 35/00, A61K 39/395, C07K 16/32, C07K 16/22, C07K 16/00
Applicant:
Genentech, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16197439

IL-17A/F HETERODIMERIC POLYPEPTIDES AND THERAPEUTIC THEREOF

IPC classification:
C07K 16/24, C07K 14/54, A61K 38/20
Applicant:
Genentech, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP15826950

ADIPONECTIN SECRETION REGULATOR

IPC classification:
A61P 43/00, A61P 3/04, A61K 45/00, A61K 31/7004
Applicant:
University of Tokyo
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16202768

IMMUNE RESPONSE INDUCER

IPC classification:
A61P 35/00, A61K 39/39, A61K 39/00, A61K 38/22, A61K 38/21
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16202866

IMMUNE RESPONSE INDUCER

IPC classification:
A61P 35/00, A61K 39/39, A61K 39/00, A61K 38/22, A61K 38/21
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16202865

IMMUNE RESPONSE INDUCER

IPC classification:
A61P 35/00, A61K 39/39, A61K 39/00, A61K 38/22, A61K 38/21
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP17158414

LUNG CANCER DIFFERENTIAL MARKER

IPC classification:
G01N 33/574, C12Q 1/02, C12N 9/64, C12N 9/26, C12N 9/16, C12N 9/14, C07K 16/40, C07K 16/32, C07K 16/28, C07K 16/18, C07K 14/82, C07K 14/78, C07K 14/705, C07K 14/47, C07K 7/08, C07K 7/06
Applicant:
Tokyo Medical University
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The application has been published
EP15845039

WHEAT FLOUR SUBSTITUTE RICE FLOUR, AND METHOD FOR MANUFACTURING GLUTEN-FREE RICE FLOUR BREAD

IPC classification:
A23L 33/10, A21D 13/04, A21D 8/04, A23L 7/104
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP15790387

SLAMF1 ANTAGONISTS AND USES THEREOF

IPC classification:
C07K 16/28
Agent:
Murgitroyd & Company
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
Request for examination was made
EP15855798

NEW PRODUCTION METHOD OF LIPOPLEX FOR LOCAL ADMINISTRATION AND ANTITUMOR DRUG USING LIPOPLEX

IPC classification:
A61P 35/00, A61K 47/24, A61K 47/18, A61K 9/127, A61K 31/7088
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP17163323

PLURIPOTENT STEM CELL THAT CAN BE ISOLATED FROM BODY TISSUE

IPC classification:
C12N 5/074
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP15858911

CELLULASE ACTIVATOR AND METHOD FOR SACCHARIFYING LIGNOCELLULOSIC BIOMASS BY USING SAME

IPC classification:
C12P 19/14, C12N 15/09, C12N 1/22, C12N 1/15, C07K 14/195, C12N 15/00
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP15860324

METHOD OF AMPLIFYING CIRCULAR DNA

IPC classification:
C12N 9/90, C12N 9/16, C12N 9/12, C12N 9/00, C12N 15/09
Applicant:
Japan Science and Technology Agency
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP17167130

METHOD FOR PREPARING NUCLEIC ACID APTAMER

IPC classification:
C12N 15/10, C12Q 1/68, A61K 31/7105, G01N 33/543, G01N 33/53, C12N 15/09, A61P 43/00, A61K 31/713, A61K 31/711, A61K 31/7088, C12N 15/115
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The application has been published
EP15864365

SENSORS, SYSTEMS AND METHEODS FOR DETECTING ANALYTES USING SAME

IPC classification:
C12M 1/34
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP15869754

PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PALLIATION OF ELDERLY OR END-STAGE CANCER PATIENT

IPC classification:
A61P 43/00, A61P 35/00, A61K 45/00, A61K 38/55
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP15823889

ANTI-CSF1R ANTIBODIES FOR TREATING PVNS

IPC classification:
A61K 39/00, C07K 16/28
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP15872245

LATENT HEAT MATERIAL-IMPREGNATED LATENT HEAT BODY HAVING EXCELLENT HEAT RESISTANCE

IPC classification:
F28D 20/02, E04B 1/80, B32B 7/02, B32B 5/18, C09K 5/06
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP17177845

METHODS OF TREATING CANCER

IPC classification:
A61P 35/00, A61K 38/18, A61K 38/00, A61K 38/17, G01N 33/53, C12Q 1/68
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16747000

ANTI-SURROGATE LIGHT CHAIN ANTIBODIES

IPC classification:
G01N 33/569, G01N 33/574, C07K 16/38, C07K 16/28, C07K 16/18
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP17159205

USE OF ARTEMISININ AND RELATED COMPOUNDS FOR TREATING ANORECTAL SQUAMOUS CELL CANCER INDUCED BY HUMAN PAPILLOMA VIRUS

IPC classification:
A61P 35/00, A61P 31/12, C07D 493/20, A61K 31/365, A61K 31/335
Applicant:
Georgetown University
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The application has been published
EP16755224

PACKAGED ARTICLE

IPC classification:
B65D 33/00, B65D 75/60
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16761670

METHOD FOR STABILIZING DNA APTAMER

IPC classification:
C12N 15/115, A61P 43/00, A61P 27/02, A61P 9/00, A61K 48/00, A61K 31/7088, C12N 15/09
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16188246

USE OF ANTI-VEGF ANTIBODY IN COMBINATION WITH CHEMOTHERAPY FOR TREATING BREAST CANCER

IPC classification:
A61K 45/06, A61P 35/04, A61K 39/395, A61K 31/704, A61K 31/675, A61K 31/513, A61K 31/337
Applicant:
F. Hoffmann-La Roche AG
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP17184546

METHOD FOR ENRICHMENT AND SEPARATION OF SPINAL FLUID GLYCOPROTEIN, METHOD FOR SEARCHING FOR MARKER FOR CENTRAL NERVOUS SYSTEM DISEASES WHICH UTILIZES THE AFOREMENTIONED METHOD, AND MARKER FOR CENTRAL NERVOUS SYSTEM DISEASES

IPC classification:
G01N 33/68
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The application has been published
EP17738512

PONZU-VINEGAR SOY SAUCE SEASONING

IPC classification:
A23L 27/21, A23L 27/20, A23L 27/00
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16718802

COMBINATION THERAPY FOR CANCER

IPC classification:
A61P 35/00, A61K 39/395, C07K 16/28
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16776566

HOT FLASH-SUPPRESSING AGENT

IPC classification:
A61P 15/12, A23L 33/19, A23L 2/52, A61K 38/00
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16786583

PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING CANCER

IPC classification:
A61P 35/02, A61P 35/00, A61K 39/395
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16786585

IMMUNITY-INDUCING AGENT

IPC classification:
A61P 37/04, A61P 35/02, A61P 35/00, A61K 48/00, A61K 35/17, A61K 35/15, A61K 31/7088, A61K 39/00
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16732377

CELL-BASED ASSAY FOR DETECTING ANTI-CD3 HOMODIMERS

IPC classification:
G01N 33/68, G01N 33/50, C12N 5/0783, C07K 16/46, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP17188907

ANTI-PD-L1 ANTIBODIES AND DIAGNOSTIC USES THEREOF

IPC classification:
G01N 33/53, C07K 16/28
Applicant:
Ventana Medical Systems, Inc.
Applicant:
Genentech, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The application has been published
EP16835086

IMMUNITY INDUCER

IPC classification:
C12N 15/09, C12N 5/10, C12N 5/0783, C07K 14/47, A61P 35/02, A61P 35/00, A61K 48/00, A61K 45/00, A61K 39/39, A61K 35/76, A61K 35/17, A61K 35/15, A61K 39/00
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP17163690

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PROPHYLAXIS OF CANCER

IPC classification:
C07K 16/18, A61K 45/06, C07K 16/28, C12P 21/08, C07K 16/30, A61P 35/00, A61K 39/395, C12N 15/09
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The application has been published
EP18151214

ANTIBODIES THAT BIND CSF1R

IPC classification:
C07K 16/28, C07H 21/04, C07K 16/00, A61K 39/395
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
The application has been published
EP16855456

ANTI-CANINE TARC ANTIBODY USED FOR TREATMENT AND DIAGNOSIS OF CANINE ATOPIC DERMATITIS

IPC classification:
G01N 33/53, C12P 21/08, C12N 15/09, C12N 5/10, C12N 1/21, C12N 1/19, C12N 1/15, C07K 16/18
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16791734

GENE SIGNATURES FOR DETERMINING ICOS EXPRESSION

IPC classification:
C12Q 1/68, C07K 16/28
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16859766

DNA APTAMER CAPABLE OF BONDING TO VWF

IPC classification:
G01N 33/53, C12Q 1/68, A61P 9/10, A61P 7/02, A61K 31/7115, C12N 15/115
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16859765

DNA APTAMER BINDING TO CANCER CELL

IPC classification:
G01N 33/574, C12Q 1/02, A61P 35/00, A61K 48/00, A61K 31/713, A61K 31/711, C12N 15/115
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made
EP16862159

PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING CANCER

IPC classification:
A61P 35/00, A61K 48/00, A61K 45/00, A61K 31/713, A61K 31/7105
Applicant:
Toray Industries, Inc.
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature